Literature DB >> 20433036

Prognostic factors associated with hepatitis C disease: a case-control study utilizing U.S. multiple-cause-of-death data.

Matthew Wise1, Lyn Finelli, Frank Sorvillo.   

Abstract

OBJECTIVE: Hepatitis C, an important cause of premature mortality, is the most common chronic bloodborne infection in the United States. The severity of disease is strongly affected by a number of other medical conditions and health behaviors. We sought to estimate the association of several exposures with hepatitis C on death certificates.
METHODS: We enrolled 63,189 hepatitis C deaths as cases in a case-control study using multiple-cause-of-death data for the U.S. from 1999 to 2004. Three control groups were assembled from all remaining deaths with no mention of hepatitis C, including a random sample of all deaths, digestive disease deaths, and circulatory disease deaths.
RESULTS: Hepatitis B, human immunodeficiency virus (HIV), hemochromatosis, and alcohol use were all strongly associated with hepatitis C, even after controlling for confounding variables. The simultaneous presence of many of these exposures had a synergistic association with hepatitis C being listed as a cause of death. Hepatitis B, HIV, and alcohol use were recorded among 6.4%, 10.5%, and 18.2% of case deaths, respectively.
CONCLUSIONS: The strong association of alcohol use, HIV, and hepatitis B with hepatitis C, as well as the frequent occurrence of these conditions, indicates that targeted interventions for mitigating the potential effect of these exposures may present an efficient means of limiting progression of hepatitis C-related liver disease and reducing the population burden of hepatitis C mortality.

Entities:  

Mesh:

Year:  2010        PMID: 20433036      PMCID: PMC2848266          DOI: 10.1177/003335491012500310

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  33 in total

1.  Quantifying biases in causal models: classical confounding vs collider-stratification bias.

Authors:  Sander Greenland
Journal:  Epidemiology       Date:  2003-05       Impact factor: 4.822

2.  Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.

Authors:  P Sadaphal; J Astemborski; N M Graham; L Sheely; M Bonds; A Madison; D Vlahov; D L Thomas; T R Sterling
Journal:  Clin Infect Dis       Date:  2001-10-12       Impact factor: 9.079

Review 3.  Analytical potential for multiple cause-of-death data.

Authors:  R A Israel; H M Rosenberg; L R Curtin
Journal:  Am J Epidemiol       Date:  1986-08       Impact factor: 4.897

4.  Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.

Authors:  C S Graham; L R Baden; E Yu; J M Mrus; J Carnie; T Heeren; M J Koziel
Journal:  Clin Infect Dis       Date:  2001-07-06       Impact factor: 9.079

5.  Isoniazid hepatotoxicity among drug users: the role of hepatitis C.

Authors:  Alberto Fernández-Villar; Bernardo Sopeña; Rafael Vázquez; Fernando Ulloa; Enrique Fluiters; Mar Mosteiro; César Martínez-Vázquez; Luis Piñeiro
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

Review 6.  Hepatitis C and HIV co-infection.

Authors:  C L S Leen
Journal:  Int J STD AIDS       Date:  2004-05       Impact factor: 1.359

Review 7.  Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.

Authors:  Richard K Sterling; Mark S Sulkowski
Journal:  Semin Liver Dis       Date:  2004       Impact factor: 6.115

Review 8.  Predicting progression to cirrhosis in chronic hepatitis C virus infection.

Authors:  A J Freeman; M G Law; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2003-07       Impact factor: 3.728

9.  Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

Authors:  Matthew Wise; Stephanie Bialek; Lyn Finelli; Beth P Bell; Frank Sorvillo
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

10.  An analysis of Berkson's bias in case-control studies.

Authors:  A R Feinstein; S D Walter; R I Horwitz
Journal:  J Chronic Dis       Date:  1986
View more
  3 in total

1.  Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.

Authors:  Berkeley N Limketkai; Shruti H Mehta; Catherine G Sutcliffe; Yvonne M Higgins; Michael S Torbenson; Sherilyn C Brinkley; Richard D Moore; David L Thomas; Mark S Sulkowski
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

2.  Hepatitis C virus infection in mothers and children.

Authors:  Emma Greenaway; Mia J Biondi; Jordan J Feld; Simon C Ling
Journal:  Can Liver J       Date:  2019-12-10

Review 3.  Hepatitis C virus infection in children and adolescents.

Authors:  James E Squires; William F Balistreri
Journal:  Hepatol Commun       Date:  2017-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.